James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 143,207 shares at $20.00 ($2.8M) on 2022-01-18, disclosed to the SEC on 2022-01-20.
Open-market sale of $2.8M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.36 | 36,144 | $700K | 25.4% |
| 2 | $19.36 | 36,144 | $700K | 25.4% |
| 3 | $20.00 | 6,793 | $136K | 4.9% |
| 4 | $18.99 | 32,063 | $609K | 22.1% |
| 5 | $18.99 | 32,063 | $609K | 22.1% |
| Total | $19.22 avg | 143,207 |
| $2.8M |
| 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |